Belpointe Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Belpointe Asset Management's HALO Position: Q2 2026 in Review
Belpointe Asset Management increased its Halozyme (HALO) stake by 3.9% in Q2 2026, buying an estimated $40.5K and bringing the position to 15,682 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #429.
Belpointe Asset Management first reported a position in HALO in Q4 2022 and has held it in 8 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Belpointe Asset Management held 15,682 shares of Halozyme worth $1.23M as of Q2 2026.
- Belpointe Asset Management bought 594 Halozyme shares in Q2 2026, an estimated $40.5K.
- Halozyme made up 0.04% of Belpointe Asset Management's portfolio in Q2 2026, its #429 holding.
- Belpointe Asset Management first reported a position in Halozyme in Q4 2022 and has held it in 8 quarters since.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.